Early supplementation withLactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?-Reference-Cited by-同舟云学术

Early supplementation withLactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?

Author:

Wickens K.¹,Stanley T. V.²,Mitchell E. A.³,Barthow C.¹,Fitzharris P.⁴,Purdie G.⁵,Siebers R.¹,Black P. N.⁶,Crane J.¹

Affiliation:

1. Wellington Asthma Research Group; Wellington School of Medicine and Health Sciences; University of Otago; Wellington; New Zealand

2. Department of Paediatrics; Wellington School of Medicine and Health Sciences; University of Otago; Wellington; New Zealand

3. Department of Paediatrics; University of Auckland; Auckland; New Zealand

4. Immunology Department; Auckland Hospital; Auckland; New Zealand

5. Dean's Department; Wellington School of Medicine and Health Sciences; University of Otago; Wellington; New Zealand

6. Department of Pharmacology & Clinical Pharmacology; University of Auckland; Auckland; New Zealand

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

Reference37 articles.

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献